Showing results (1-10 of 74) with videos related to
Sort By:
Pageof 8
Biochemical Pharmacology|May 19, 2015
David Triggle: Research collaborations and scientific exchanges with the China Pharmaceutical University, Nanjing, ChinaDe-Zai DaiCurrent Opinion in Investigational Drugs (London, England : 2000)|April 9, 2005
Two patterns of ion channelopathy in the myocardium: perspectives for development of anti-arrhythmic agentsDe-Zai DaiCardiovascular Drug Reviews|September 12, 2006
CPU86017: a novel Class III antiarrhythmic agent with multiple actions at ion channelsDe-Zai DaiVascular Health and Risk Management|September 23, 2010
Role of endothelin receptor A and NADPH oxidase in vascular abnormalitiesDe-Zai Dai, Yin DaiCurrent Opinion in Investigational Drugs (London, England : 2000)|August 30, 2008
Induced ion currents and the endothelin pathway as targets for anti-arrhythmic agentsDe-Zai Dai, Yin DaiActa Pharmacologica Sinica|July 26, 2005
Ion channelopathy and hyperphosphorylation contributing to cardiac arrhythmiasDe-zai Dai, Feng YuClinical and Experimental Pharmacology & Physiology|January 25, 2008
Effect of the endothelin receptor antagonist CPU0213, and its modulation by rifampin, on cardiac and vascular tissue following chronic isoproterenol treatmentLu Luo, De-Zai Dai, Yin DaiNaunyn-Schmiedeberg'S Archives of Pharmacology|June 13, 2008
CPU86017 and its isomers improve hypoxic pulmonary hypertension by attenuating increased ETA receptor expression and extracellular matrix accumulationNa Li, De-Zai Dai, Yin DaiAmerican Journal of Nephrology|September 20, 2008
Normalizing NADPH oxidase contributes to attenuating diabetic nephropathy by the dual endothelin receptor antagonist CPU0213 in ratsMing Xu, De-Zai Dai, Yin DaiEuropean Journal of Pharmacology|October 19, 2013
AQP4 KO exacerbating renal dysfunction is mediated by endoplasmic reticulum stress and p66Shc and is attenuated by apocynin and endothelin antagonist CPU0213Yu-Si Cheng, De-Zai Dai, Yin DaiPageof 8